Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA0B2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,898
Award facts
- Contract value 100% obligated
- $32,897.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $32,897.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Wegovy (semaglutide) 1 mg/0.5 mL pen injections, with a completion date of December 18, 2025. This non-compete, competitively awarded delivery order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion master contract vehicle valued through December 2026 that authorizes AmerisourceBergen to supply a comprehensive range of pharmaceuticals and medical supplies globally to support military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of federal contract awards predominantly with the DLA Medical Supply Chain. The company's federal contracting demonstrates significant capability in delivering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Wegovy reflects AmerisourceBergen's role in supplying specialized pharmaceutical products to support military personnel and veteran healthcare needs within the broader scope of its comprehensive pharmaceutical prime vendor agreement with DLA.
Quick answers
Who was awarded contract SPE2DR26FA0B2?
SPE2DR26FA0B2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FA0B2 worth?
The government has obligated $32,898 on SPE2DR26FA0B2.
Is contract SPE2DR26FA0B2 an order under another contract?
Yes. SPE2DR26FA0B2 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA0B2 competed?
The extent of competition for SPE2DR26FA0B2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award